Aristeidis G. Vaiopoulos

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Sustained Minimal Disease Activity With Upadacitinib and Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A 104-Week, Real-World, Retrospective Study.

Sustained Minimal Disease Activity With Upadacitinib and Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A 104-Week, Real-World, Retrospective Study.

Journal: International journal of dermatology

Published: May 10, 2026

Drug survival of bimekizumab, guselkumab, and risankizumab after secondary IL-17 inhibitor failure.

Drug survival of bimekizumab, guselkumab, and risankizumab after secondary IL-17 inhibitor failure.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 05, 2026

Long-Term Effectiveness and Safety of Abrocitinib in Patients with Atopic Dermatitis: A Real-World, Retrospective Study.

Long-Term Effectiveness and Safety of Abrocitinib in Patients with Atopic Dermatitis: A Real-World, Retrospective Study.

Journal: Dermatology and therapy

Published: January 06, 2026

Real-world efficacy and safety of ixekizumab from the joint psoriasis and psoriatic arthritis clinic.

Real-world efficacy and safety of ixekizumab from the joint psoriasis and psoriatic arthritis clinic.

Journal: Clinical and experimental dermatology

Published: October 03, 2025

Long-Term Outcomes of Guselkumab and Risankizumab for the Management of Moderate-to-Severe Psoriasis in the Elderly: Results from a Real-World Retrospective Study.

Long-Term Outcomes of Guselkumab and Risankizumab for the Management of Moderate-to-Severe Psoriasis in the Elderly: Results from a Real-World Retrospective Study.

Journal: Journal of clinical medicine

Published: July 25, 2025

Long-term outcomes of upadacitinib in patients with prior dupilumab exposure: a case series.

Long-term outcomes of upadacitinib in patients with prior dupilumab exposure: a case series.

Journal: Archives of dermatological research

Published: November 21, 2024

Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre Study.

Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre Study.

Journal: Dermatology and therapy

Published: November 13, 2024

Real-World Data From the Joint Psoriasis-Psoriatic Arthritis Clinic (PPAC) on the Efficacy of Bimekizumab in Patients With Psoriasis and Psoriatic Arthritis.

Real-World Data From the Joint Psoriasis-Psoriatic Arthritis Clinic (PPAC) on the Efficacy of Bimekizumab in Patients With Psoriasis and Psoriatic Arthritis.

Journal: International journal of dermatology

Published: October 22, 2024

The Effect of 4-Month Treatment with Glycocalyx Dietary Supplement on Endothelial Glycocalyx Integrity and Vascular Function in Patients with Psoriasis.

The Effect of 4-Month Treatment with Glycocalyx Dietary Supplement on Endothelial Glycocalyx Integrity and Vascular Function in Patients with Psoriasis.

Journal: Nutrients

Published: July 22, 2024

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real-world data from a multicentre study.

Effectiveness and safety of methotrexate in the treatment of mycosis fungoides: Real-world data from a multicentre study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 20, 2024

Rotational Thromboelastometry as a Diagnostic Tool for Persistent Infection in Two-Stage Exchange Arthroplasty.

Rotational Thromboelastometry as a Diagnostic Tool for Persistent Infection in Two-Stage Exchange Arthroplasty.

Journal: Journal of clinical medicine

Published: March 12, 2024

Insights, Advantages, and Barriers of Teledermatology vs. Face-to-Face Dermatology for the Diagnosis and Follow-Up of Non-Melanoma Skin Cancer: A Systematic Review.

Insights, Advantages, and Barriers of Teledermatology vs. Face-to-Face Dermatology for the Diagnosis and Follow-Up of Non-Melanoma Skin Cancer: A Systematic Review.

Journal: Cancers

Published: October 04, 2023

Showing 1-12 of 48

Last Updated: 09/26/2026